跳至主要内容
临床试验/JPRN-UMIN000011938
JPRN-UMIN000011938已完成2 期

Granulocyte colony-stimulating factor-mediated neuroprotective therapy for acute aggravation of cervical compressive myelopathy: multicenter placebo controlled randomized single blinded trial. - Granulocyte colony-stimulating factor-mediated neuroprotective therapy for acute aggravation of cervical compressive myelopathy: multicenter placebo controlled randomized single blinded trial.

Department of Orthopedic Surgery, Chiba University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2013年10月4日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • allergy for G-CSF, history of the malignancy of hematopoietic system, history of malignancy within 5 years, thoromboembolism, splenomegaly, disturbance of consciousness, pregnancy

研究者

发起方
Department of Orthopedic Surgery, Chiba University Graduate School of Medicine

相似试验